HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chi-Ming Che Selected Research

Cytokines

10/2023Nasopharynx Battlefield: Cellular Immune Responses Mediated by Midkine in Nasopharyngeal Carcinoma and COVID-19.
12/2010Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin.
1/2007Topical delivery of silver nanoparticles promotes wound healing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chi-Ming Che Research Topics

Disease

59Neoplasms (Cancer)
04/2024 - 07/2003
13Hepatocellular Carcinoma (Hepatoma)
12/2023 - 04/2005
7Neoplasm Metastasis (Metastasis)
01/2023 - 02/2006
7Carcinoma (Carcinomatosis)
09/2020 - 12/2003
6Nasopharyngeal Carcinoma
10/2023 - 07/2006
4Lung Neoplasms (Lung Cancer)
01/2022 - 03/2019
4Insulin Resistance
01/2019 - 12/2010
4Inflammation (Inflammations)
05/2015 - 01/2007
3Mitochondrial Diseases (Mitochondrial Disease)
01/2016 - 12/2007
3Breast Neoplasms (Breast Cancer)
06/2013 - 01/2010
3Neuroblastoma
01/2012 - 01/2010
3Wounds and Injuries (Trauma)
03/2010 - 01/2007
2COVID-19
10/2023 - 10/2023
2Carcinogenesis
01/2017 - 01/2012
2Burns
07/2009 - 01/2007
2Leukemia
12/2007 - 04/2006
1Communicable Diseases (Infectious Diseases)
10/2023
1Rheumatoid Arthritis
01/2020
1Obesity
01/2019
1Ovarian Neoplasms (Ovarian Cancer)
03/2017

Drug/Important Bio-Agent (IBA)

29GoldIBA
10/2020 - 07/2003
11LigandsIBA
04/2024 - 02/2005
11PorphyrinsIBA
10/2020 - 07/2003
9Cisplatin (Platino)FDA LinkGeneric
01/2021 - 07/2003
9Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2006
8PlatinumIBA
12/2021 - 10/2005
7DNA (Deoxyribonucleic Acid)IBA
01/2019 - 07/2003
6carbeneIBA
01/2021 - 06/2010
4LipidsIBA
05/2015 - 12/2010
4gold (III) porphyrin 1aIBA
06/2011 - 01/2006
3MetalsIBA
10/2023 - 07/2006
3Biomarkers (Surrogate Marker)IBA
10/2023 - 02/2006
3CytokinesIBA
10/2023 - 01/2007
3Sulfhydryl Compounds (Thiols)IBA
01/2020 - 03/2013
3IronIBA
02/2015 - 09/2005
3tetraphenylporphyrinIBA
05/2013 - 08/2010
3SilverIBA
03/2010 - 01/2007
2Clathrin Light ChainsIBA
12/2023 - 01/2023
2Sorafenib (BAY 43-9006)FDA Link
12/2023 - 10/2019
2Glucose (Dextrose)FDA LinkGeneric
12/2021 - 12/2010
2Antineoplastic Agents (Antineoplastics)IBA
01/2020 - 01/2016
2ProteomeIBA
11/2019 - 02/2006
2Therapeutic UsesIBA
10/2019 - 01/2010
2HydrogelsIBA
03/2019 - 07/2015
2PalladiumIBA
01/2018 - 01/2016
2CateninsIBA
01/2018 - 01/2011
2RutheniumIBA
10/2016 - 11/2007
2Peptides (Polypeptides)IBA
05/2016 - 08/2005
2Sirtuin 1IBA
05/2015 - 01/2013
2Biotin (Vitamin H)FDA Link
05/2015 - 01/2013
2phosphine (phosphane)IBA
09/2011 - 07/2006
2SolventsIBA
06/2011 - 02/2005
2PoisonsIBA
01/2011 - 06/2010
2Coordination ComplexesIBA
11/2010 - 11/2007
2Phenylalanine (L-Phenylalanine)FDA Link
06/2009 - 02/2005
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2008 - 12/2007
2dioscinIBA
12/2007 - 04/2006
1IonsIBA
04/2024
1Proteasome Endopeptidase Complex (Proteasome)IBA
04/2024
1pitstop 2IBA
12/2023
1SeleniumIBA
10/2023
1MidkineIBA
10/2023
1Immunologic Factors (Immunomodulators)IBA
10/2023
1PPAR alphaIBA
03/2023
1artenimol (dihydroartemisinin)IBA
03/2023
1Fatty Acid-Binding ProteinsIBA
03/2023
1Immune Checkpoint InhibitorsIBA
11/2022
1Interferon Type IIBA
11/2022
1VimentinIBA
01/2021
1Ubiquitinated ProteinsIBA
01/2020
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2020
1Protein AggregatesIBA
01/2020
1Cysteine (L-Cysteine)FDA Link
01/2020
1SulfurIBA
01/2020
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
11/2019
1mevalonolactoneIBA
11/2019
1diphosphoric acid (pyrophosphoric acid)IBA
11/2019
1Mevalonic Acid (Mevalonate)IBA
11/2019
1Auranofin (Ridaura)FDA Link
11/2019
1Galectin 1 (LGALS1)IBA
10/2019
1compound 0118IBA
10/2019
11-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
10/2019
1Complement System Proteins (Complement)IBA
03/2019
1GelatinIBA
03/2019
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
03/2019
1Carrier Proteins (Binding Protein)IBA
01/2019
1AsparagineIBA
01/2019
1SelenocysteineIBA
01/2019
1Drug CarriersIBA
03/2017
1EstersIBA
03/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2017
1Peptide Initiation Factors (Initiation Factor)IBA
01/2017
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2016
1genipinIBA
07/2016

Therapy/Procedure

5Therapeutics
11/2022 - 01/2012
3Drug Therapy (Chemotherapy)
01/2021 - 04/2009
3Intraperitoneal Injections
10/2009 - 03/2006
2Injections
03/2019 - 01/2010
1Rejuvenation
11/2022
1Precision Medicine
09/2020